Antitrust: Preliminary Report On Pharmaceutical Sector Inquiry Highlights Cost Of Pharma Companies’ Delaying Tactics - European Commission

The European Commission has published its preliminary report on the competition inquiry into the pharmaceutical sector, which finds that competition in this industry does not work as well as it should. According to the preliminary findings there is evidence that originator companies have engaged in practices with the objective of delaying or blocking market entry of competing medicines.

More: continued here

Filed under: Pharma Industry on December 2nd, 2008